申请人:Sugihara Yoshihiro
公开号:US20080269238A1
公开(公告)日:2008-10-30
The present invention provides a compound represented by the following Formula:
wherein A is an aryl group or a heteroaryl group, each of which may be substituted; R
1
is a group which is bonded through carbon; R
2
is hydrogen or an aliphatic hydrocarbon group; and X is —NR
3
—, —O—, —S—, —SO—, —SO
2
—, or —CHR
3
— (wherein R
3
is hydrogen or an aliphatic hydrocarbon group), or a salt thereof, or a prodrug thereof, which has growth factor receptor tyrosine kinase inhibitory activity and low toxicity, and is useful for prevention and treatment of cancer, and thus can be sufficiently used as a medicine.
本发明提供了以下式子所表示的化合物:其中,A是芳基或杂芳基,每个都可以被取代;R1是通过碳键结合的基团;R2是氢或脂肪烃基团;X是-NR3-、-O-、-S-、-SO-、-SO2-或-CHR3-(其中,R3是氢或脂肪烃基团),或其盐或前药。该化合物具有生长因子受体酪氨酸激酶抑制活性和低毒性,并且对于预防和治疗癌症非常有用,因此可以充分用作药物。